Tak Paul Peter

Tak Paul Peter is listed in filings as Chief Executive Officer at Candel Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 28, 2026, including sale activity. Recent filings connect the profile to Candel Therapeutics, Inc. (CADL). The current snapshot covers public activity from Jul 15, 2024 to Jan 28, 2026. Reported amounts are shown as $121.2K to $20.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.